Skip navigation

Navigate Regulatory Changes, Develop Strategies for Sharing Patient Data, and Elevate Medical Writing

January 22-24, 2020
  • Coral Gables, FL

Join CBI’s 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries to discuss and disseminate the latest information during a time of industry reform. The clinical data transparency landscape is shifting as U.S. and global regulations are continuing to evolve. At this conference, gain insight from an expert speaking faculty, navigate regulatory changes, develop strategies for data and document anonymization, achieve meaningful patient engagement and spend your time with a laser focus on data sharing.

Meet Our Advisory Board

Nate Root
Associate Director Clinical
Disclosure and Transparency
Ionis Pharmaceuticals

Liz Roberts
Global Public Policy Lead, External Engagement Practice
UCB

Kelly Coulbourne
Associate Director, Clinical Trial Data Registries
Allergan

Julie Holtzople
Director, Clinical Trial Transparency Operations
AstraZeneca

Paul Ngai, M.S.
Co-founder & Chief Executive Officer
Xogene

Key Insights and Takeaways:

  • Prepare your organization for
    Health Canada Implementation
  • Gain insight on stakeholder perspectives of
    Clinical Data and Data Sharing
  • Explore global regulations and guidance’s
    effect disclosure and transparency
  • Identify strategies to come together as
    an industry amid regulations

Don’t miss the chance to join this important discussion. See you there!

Previous Attendee Acclaim:

Really great conference focused on the nuances and challenges in the niche field of Clinical data transparency. It is helping move the cause of data sharing by pulling in all key stakeholders to the table for engaging conversation.

Duke Clinical Research Institute

Getting updated on guidelines and learning real-life
solutions from lively conversations and networking in a
smaller venue that allows for more interactions.

Director, Medical Communications, Myokardia

A great way to learn about the challenges being faced by
other companies and proposed solutions.

Director, CTT, Xogene Services

The CBI conference was a great value. Excellent speakers and discussion provided a 360-degree view of each issue. It is such
a pleasure to be in the disclosure community where we
share knowledge and ideas with peers – as well as
the key opinion leaders of tomorrow.

Manager, Clinical Trial Information Disclosure, Daiichi Sankyo, Inc.

CBI's transparency programs are second to none when
it comes to the quality of presentations!

Head of Marketing, TrialAssure

7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries

Navigate Regulatory Changes, Develop Strategies for Sharing Patient Data, and Elevate Medical Writing

Join CBI’s 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries to discuss and disseminate the latest information during a time of industry reform. The clinical data transparency landscape is shifting as U.S. and global regulations are continuing to evolve. At this conference, gain insight from an expert speaking faculty, navigate regulatory changes, develop strategies for data and document anonymization, achieve meaningful patient engagement and spend your time with a laser focus on data sharing.

Meet Our Advisory Board

Nate Root
Associate Director Clinical
Disclosure and Transparency
Ionis Pharmaceuticals

Liz Roberts
Global Public Policy Lead, External Engagement Practice
UCB

Kelly Coulbourne
Associate Director, Clinical Trial Data Registries
Allergan

Julie Holtzople
Director, Clinical Trial Transparency Operations
AstraZeneca

Paul Ngai, M.S.
Co-founder & Chief Executive Officer
Xogene

Key Insights and Takeaways:

  • Prepare your organization for
    Health Canada Implementation
  • Gain insight on stakeholder perspectives of
    Clinical Data and Data Sharing
  • Explore global regulations and guidance’s
    effect disclosure and transparency
  • Identify strategies to come together as
    an industry amid regulations

Don’t miss the chance to join this important discussion. See you there!

Previous Attendee Acclaim:

Really great conference focused on the nuances and challenges in the niche field of Clinical data transparency. It is helping move the cause of data sharing by pulling in all key stakeholders to the table for engaging conversation.

Duke Clinical Research Institute

Getting updated on guidelines and learning real-life
solutions from lively conversations and networking in a
smaller venue that allows for more interactions.

Director, Medical Communications, Myokardia

A great way to learn about the challenges being faced by
other companies and proposed solutions.

Director, CTT, Xogene Services

The CBI conference was a great value. Excellent speakers and discussion provided a 360-degree view of each issue. It is such
a pleasure to be in the disclosure community where we
share knowledge and ideas with peers – as well as
the key opinion leaders of tomorrow.

Manager, Clinical Trial Information Disclosure, Daiichi Sankyo, Inc.

CBI's transparency programs are second to none when
it comes to the quality of presentations!

Head of Marketing, TrialAssure